Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma
Clinical trial NCT06474481 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06474481
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2027-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.